Cyproheptadine : a psychopharmacological treasure trove?

Bassem Badr 1, Ahmed Naguy

Affiliations

01 October 2022

-

doi: 10.1017/S1092852921000250

Abstract

Cyproheptadine has a unique pharmacologic portfolio that speaks to the idea of a pluripotent molecule beyond an antiallergic agent which can expand its therapeutic potential to address a multitude of psychiatric indications. Here, authors touch on the topic with focused literature review of extant evidence.

Keywords: Cyproheptadine; psychiatric uses; psychopharmacology.

Similar articles

[Rupatadine, oral Rupatall].

[No authors listed]J Pharm Belg. 2010 Mar;(1):24.PMID: 20429393 French. No abstract available.

Further studies of cyproheptadine as an antiallergic, antipruritic agent.

WELSH AL, EDE M.J New Drugs. 1962 Mar-Apr;2:88-93. doi: 10.1177/009127006200200204.PMID: 14006060 No abstract available.

[Antiallergic properties of the cyproheptadine-dexamethasone combination. Antiserotonin activity of cyprohepatadine].

GIRARD JP.Praxis. 1962 Jan 18;51:67-70.PMID: 13898852 French. No abstract available.

Rupatadine: a review of its use in the management of allergic disorders.

Keam SJ, Plosker GL.Drugs. 2007;67(3):457-74. doi: 10.2165/00003495-200767030-00008.PMID: 17335300 Review.

Galantamine beyond Alzheimer's disease-a fact or artefact?

Naguy A, Husain K, Alamiri B.CNS Spectr. 2022 Jun;27(3):268-271. doi: 10.1017/S1092852920002229. Epub 2020 Dec 14.PMID: 33308343 Review.

KMEL References

https://pubmed.ncbi.nlm.nih.gov/

Page Navigation